Obstacles to Early Diagnosis and Treatment of Hidradenitis Suppurativa: Current Perspectives on Improving Clinical Management.

Clin Cosmet Investig Dermatol · 2023 · PMC10361090 · PMID 37483473

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

11 While HiSCR50 remains the historical primary endpoint in many trials, fifty percent improvement in disease may not be significant for all patients and can still represent a significant disease burden.

also in 1,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.